News and Events
News and Events
You may sort news and events by title or recency. If you wish to view only news, please select the news link from the left. If you wish to see events at which Quintiles is scheduled to participate, please select the events link from the left.
- Sort by: Most Recent
- Title
-
AGREEMENT EXPANDS QUINTILES CAPABILITIES TO SUPPORT DRUG APPROVALS IN JAPAN
May 5, 2004 –Quintiles Transnational Corp. today announced an agreement to conduct clinical trials in Peru involving ethnic Japanese, further expanding the company's ability to support new drug applications in Japan. -
BIOFOCUS AND QUINTILES ANNOUNCE LAUNCH OF NEW HIGH-THROUGHPUT SCREENING SERVICE TO DETECT CARDIO-TOXIC COMPOUNDS
19 February 2002 -- BioFocus plc (LSE: BIO) and Quintiles Transnational Corp. (Nasdaq: QTRN) have announced the launch of a new screening service for the rapid and early detection of potential cardiac side-effects caused by drug candidates and lead molecules. The two companies will jointly market the new service. The assay work will be carried out at BioFocus' advanced biology facility at Cambridge Science Park in the United Kingdom. -
COMMERCE SECRETARY FAIN JOINS QUINTILES IN DEDICATING NEW DATA PROCESSING CENTER IN EASTERN NORTH CAROLINA
Feb. 13, 2007 – Dennis Gillings, CBE, Chairman and CEO of Quintiles Transnational Corp., was joined yesterday in the formal opening of Quintiles’ new data processing facility in Williamston, N.C., by North Carolina Commerce Department Secretary Jim Fain, together with N.C. Rep. Edith Warren; Tommy Bowen, Chairman of the Martin County Board of Commissioners; Stan Crowe, Chairman of the Martin County Economic Development Commission; and Jane Patterson, Executive Director of the e-NC Authority, a division of the North Carolina Rural Economic Development Center. -
COURT FINDS IN FAVOR OF QUINTILES
March 21, 2001 -Quintiles Transnational Corp. (Nasdaq: QTRN) today announced that U.S. District Court Judge Terrence W. Boyle issued a new order continuing the preliminary injunction against WebMD that had been issued on Friday, March 16, 2001. -
COURT ORDERS WEBMD TO CONTINUE UNINTERRUPTED AND UNALTERED DATA DELIVERY TO QUINTILES
March 19, 2001 - Quintiles Transnational Corp. (Nasdaq: QTRN) today announced that on Friday, March 16, U.S. District Court Judge Terrence W. Boyle issued a preliminary injunction against WebMD. The court's order states, "WebMD is ordered to continue the uninterrupted and unaltered flow of data to Quintiles as represented before this court during the hearing on March 15, 2001, in Greenville, North Carolina." The preliminary injunction will continue until further notice, the order states. -
DATATRAK AND QUINTILES SIGN AGREEMENT FOR DEPLOYMENT OF DUAL PLATFORM ELECTRONIC DATA CAPTURE TECHNOLOGY
June 30, 1999 - DataTRAK International, Inc. (Nasdaq: DATA) today announced a worldwide, 3-year, software license and master services agreement with Quintiles, Inc. The software agreement is mutually nonexclusive between DataTRAK, a leader in worldwide use of Electronic Data Capture (EDC) and Quintiles, Inc., the Product Development service group of Quintiles Transnational Corp. (Nasdaq: QTRN), the leading healthcare services company to the pharmaceutical industry. -
DIA Latin America 2009
September 23 - September 25, 2009
6th Annual Latin American Congress of Clinical Research -
DRKOOP.COM AND QUINTILES LAUNCH SERVICE TO RECRUIT CLINICAL TRIAL PATIENTS ON THE INTERNET
June 28, 1999 - drkoop.com (Nasdaq: KOOP) and Quintiles Transnational Corp. (Nasdaq: QTRN) today announced the launch of the first interactive, consumer Internet resource to enable interested individuals to sign up on-line for possible participation in clinical drug trials via the www.drkoop.com Web site. -
EIDETICS LAUNCHES GROUNDBREAKING DATA VISUALIZATION
October 24, 2008 - Eidetics, a leading global healthcare market research firm and division of Quintiles Consulting, announced the commercial launch of their proprietary service application, Provenance. -
EXPERT CARDIOLOGIST JOINS QUINTILES MEDICAL GROUP
October 26, 2007 – Quintiles Transnational Corp. today announced that Christopher H. Cabell, M.D., MHS, FACC, an expert cardiologist and clinical investigator, has joined the Medical & Scientific Services group in Global Clinical Development Services (CDS). In addition to his CDS work, he provides U.S.-based cardiology expertise for Quintiles ECG Services.